Simvastatin in Preventing a New Breast Cancer in Women at High Risk for a New Breast Cancer
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing,
or coming back. The use of simvastatin may keep cancer from coming back in women who are at
high risk for a new breast cancer after undergoing surgery for ductal carcinoma in situ or
stage I, stage II, or stage III breast cancer.
PURPOSE: This phase II trial is studying how well simvastatin works in preventing a new
breast cancer in women at high risk for a new breast cancer after undergoing surgery for
ductal carcinoma in situ or stage I, stage II, or stage III breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins